Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction

被引:27
|
作者
Li, Chong [1 ]
Zhan, Changyou [2 ,3 ]
Zhao, Le [2 ,3 ]
Chen, Xishan [4 ,5 ]
Lu, Wei-Yue [4 ,5 ]
Lu, Wuyuan [2 ,3 ,4 ,5 ]
机构
[1] Southwest Univ, Coll Pharmaceut Sci, Chongqing 400715, Peoples R China
[2] Univ Maryland Sch Med, Inst Human Virol, Baltimore, MD 21201 USA
[3] Univ Maryland Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA
[4] Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China
[5] Fudan Univ Sch Pharm, PLA, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金; 美国国家卫生研究院;
关键词
Retro-inverso peptide; p53; MDM2; MDMX; D-Peptide; Apamin; Stingin; D-PEPTIDE INHIBITORS; P53; PATHWAY; AFFINITY; MDM2; ACTIVATION; DESIGN; ENANTIOMERS; MIMICRY;
D O I
10.1016/j.bmc.2013.04.039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptide retro-inverso isomerization is thought to be functionally neutral and has been widely used as a tool for designing proteolytically stable D-isomers to recapitulate biological activities of their parent L-peptides. Despite success in a wide range of applications, exceptions amply exist that clearly defy this rule of thumb when parent L-peptides adopt an a-helical conformation in their bound state. The detrimental energetic effect of retro-inverso isomerization of an a-helical L-peptide on its target protein binding has been estimated to be 3.0-3.4 kcal/mol. To better understand how the retro-inverso isomer of a structured protein works at the molecular level, we chemically synthesized and functionally characterized the retro-inverso isomer of a rationally designed miniature protein termed stingin of 18 amino acid residues, which adopts an N-terminal loop and a C-terminal alpha-helix stabilized by two intra-molecular disulfide bridges. Stingin emulated the transactivation peptide of the p53 tumor suppressor protein and bound with high affinity and via its C-terminal a-helix to MDM2 and MDMX-the two negative regulators of p53. We also prepared the retro isomer and D-enantiomer of stingin for comparative functional studies using fluorescence polarization and surface plasmon resonance techniques. We found that retro-inverso isomerization of L-stingin weakened its MDM2 binding by 720 fold (3.9 kcal/mol); while enantiomerization of L-stingin drastically reduced its binding to MDM2 by three orders of magnitude, sequence reversal completely abolished it. Our findings demonstrate the limitation of peptide retro-inverso isomerization in molecular mimicry and reinforce the notion that the strategy works poorly with biologically active a-helical peptides due to inherent differences at the secondary and tertiary structural levels between an L.-peptide and its retro-inverso isomer despite their similar side chain topologies at the primary structural level) (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4045 / 4050
页数:6
相关论文
共 50 条
  • [41] The qualitative analysis for a differential system of the P53-Mdm2 interaction with delay kernel
    Horhat, Paul Florin
    Neamtu, Mihaela
    Opris, Dumitru
    PROCEEDINGS OF THE 1ST WSEAS INTERNATIONAL CONFERENCE ON BIOMEDICAL ELECTRONICS AND BIOMEDICAL INFORMATICS, 2008, : 208 - +
  • [42] Cyclic β-Hairpin-like Peptidomimetics as p53-MDM2 Interaction Inhibitors
    Jain, Priyesh
    Liang, Yi
    Li, Xiaolong
    Badger, David
    Chen, Jiandong
    McLaughlin, Mark L.
    BIOPOLYMERS, 2011, 96 (04) : 459 - 459
  • [43] A Left-Handed Solution to Peptide Inhibition of the p53-MDM2 Interaction
    Liu, Min
    Pazgier, Marzena
    Li, Changqing
    Yuan, Weirong
    Li, Chong
    Lu, Wuyuan
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (21) : 3649 - 3652
  • [44] A nonpeptidic sulfonamide inhibits the p53-mdm2 interaction and activates p53-dependent transcription in mdm2-overexpressing cells
    Galatin, PS
    Abraham, DJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) : 4163 - 4165
  • [45] MYCN interaction with the p53/MDM2/p14ARF network in neuroblastoma and response to p53-MDM2 antagonists
    Gamble, Laura
    Tweddle, Deborah
    Lunec, John
    CANCER RESEARCH, 2009, 69
  • [46] Sulfonamide derivatives of cis-imidazolines as potent p53-MDM2/MDMX protein-protein interaction inhibitors
    Bazanov, Daniil R.
    Pervushin, Nikolay, V
    Savin, Egor, V
    Tsymliakov, Michael D.
    Maksutova, Anita, I
    Sosonyuk, Sergey E.
    Kopeina, Gelina S.
    Lozinskaya, Natalia A.
    MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (12) : 2216 - 2227
  • [47] Sulfonamide derivatives of cis-imidazolines as potent p53-MDM2/MDMX protein-protein interaction inhibitors
    Daniil R. Bazanov
    Nikolay V. Pervushin
    Egor V. Savin
    Michael D. Tsymliakov
    Anita I. Maksutova
    Sergey E. Sosonyuk
    Gelina S. Kopeina
    Natalia A. Lozinskaya
    Medicinal Chemistry Research, 2021, 30 : 2216 - 2227
  • [48] Mathematical analysis of a generalised p53-Mdm2 protein gene expression model
    Piotrowska, Monika J.
    Bartlomiejczyk, Agnieszka
    Bodnar, Marek
    APPLIED MATHEMATICS AND COMPUTATION, 2018, 328 : 26 - 44
  • [49] Evaluating the activity of the p53-MDM2 inhibitor NDD0005 in Ewing sarcoma
    Pecqueur, J.
    Vormoor, B.
    Zhao, Y.
    Newell, H.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 133 - 133
  • [50] Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction
    Maciej Pawel Ciemny
    Aleksander Debinski
    Marta Paczkowska
    Andrzej Kolinski
    Mateusz Kurcinski
    Sebastian Kmiecik
    Scientific Reports, 6